Anand Parikh

CEO at @faethtx, Ex @virtahealth. Healthcare nut, technology lover. Tottenham Hotspur fan #COYS

[Anand Parikh @anandparikh]

@MarcusDGon Thanks @MarcusDGon for fearlessly pursuing the science in whichever direction it led, even when it wasn't the initial path we set out on. Excited to see you next week!

[Poet @poetscorneruk]

Never forget Harry Kane is doing all of this in sketchers

[Isiah Whitlock Jr. @IsiahWhitlockJr]

S
h
e
e
e
e
e
e
e
e
e
-
i
t
!

[Robert Nelsen @rtnarch]

If we lose to China in biotech, the proximal, nucleating cause, will be the failure of our regulatory apparatus to respond with a more decentralized, IRB and Investigator-driven, fast path to human proof of concept, without massive manufacturing burden. Fix it.

[Patrick Collison @patrickc]

Remarkable that US spending on pharmaceuticals is just ~1.6% of GDP. Amazingly good value for money considering the welfare gains. (And especially given the extent to which the US subsidizes the rest of the world.)

[Nathan Frazer @WWEFrazer]

Alright I’m pretty sure at this point that being a fan of Tottenham Hotspur football club is part of some sick, twisted social experiment

[Anand Parikh @anandparikh]

Congratulations to @celcuity on their positive Phase 3 data. At @FaethTx we definitely agree that multi-node inhibition of the PI3K pathway is the way forward.

[Celcuity @celcuity]

#NEWS We’re excited to share positive topline data from our Phase 3 VIKTORIA-1 trial evaluating our lead candidate, a multi-target PI3K/AKT/mTOR inhibitor, as a treatment option for HR+/HER2- advanced breast cancer patients.

Learn more here: https://t.co/BMI6k1HpZ1
#meded #medex

[Paul O Keefe @pokeefe1]

We're having a go. Finally

[Anand Parikh @anandparikh]

Some got more air than others, and it took me way too long to get a picture that works but glad to be working on uterine cancer. It’s an important disease that deserves more attention.

[Anand Parikh @anandparikh]

This is so weak. Why write in the “we” - this was clearly a decision by Daniel Levy.

[Tottenham Hotspur @SpursOfficial]

Following a review of performances and after significant reflection, the Club can announce that Ange Postecoglou has been relieved of his duties.

[Anand Parikh @anandparikh]

Honestly the lack of awareness around endometrial cancer is scary. Only cancer indication that is growing in incidence and mortality. We have to do more and proud of the entire team @FaethTx for dedicating themselves to this work!

[Tottenham Hotspur @SpursOfficial]

😎

[Harry Kane @HKane]

congratulations @SpursOfficial 🤍

[george @StokeyyG2]

Absolute carnage at the Tottenham Hotspur stadium 🤣🤣�

[The Spurs Web @thespursweb]

Just look at those LIMBS inside the Tottenham Hotspur Stadium

[Anand Parikh @anandparikh]

@adamfeuerstein Great win and hopefully we smash Man U. I still think Ange goes. I love him but he is displaying the same behavioral spiral as Conte and Mourinho.

[Anand Parikh @anandparikh]

For decades, we bet on chemistry—hit the target, block the pathway. But disease isn’t just chemistry. It’s biology: metabolism, immunity, networks in motion. ML is finally decoding the system. The next great medicines will come from new modalities that integrate that multi-faceted future.

https://t.co/Sqj32HeJCG

[Anand Parikh @anandparikh]

@_Tony_Morris_ Yeah we heard it too. Sounded massive. Gas explosion?

[Anand Parikh @anandparikh]

Most people using ML in biotech focus on the predictable - chemistry and physics. But biology is the key to unlocking new breakthroughs for patients.

I had the opportunity to pen my thoughts in this column with @DrugDiscoverDev . Give it a read and lmk what you think.
https://t.co/DjDwTFy3w7

[Anand Parikh @anandparikh]

Great job @AndrewE_Dunn - fun read. Was wonderful catching up with you in NYC a couple weeks ago!

[Andrew Dunn @AndrewE_Dunn]

NEW: I sat down (virtually) with biotech's Renaissance man, @DrSidMukherjee

We talked about AI, his slew of ambitious biotech startups, and how he got into writing epic, Pulitzer-winning tomes on medicine and science

The latest @endpts Slack edition:
https://t.co/nILbUE9TV7